RE:RE:RE:RE:RE:RE:Supply Picture - Economics 101 Yada Yada, stocks go up, and go down while waiting for true direction. Schocor, what you and many many others fail to recognize through your "present value" tunnel vision is the macro picture. We are in the infancy of a new and legal investment opportunity that has unlimited growth potential. MJ uses vary from alcohol products, to CBD oils, edibles, pharmaceuticals, and just plain smoking/vaping and there will be other uses, trust me. Once we hit legalization I believe we will begin witnessing another wave of M&A activity, except it's going to be the likes of Altria (MO 107B market cap) or Pfizer (218B market cap) picking off the likes of WEED, ACB and APH (each only 4-5 B market cap). Picking off one of these is a drop in the bucket for big tobacco and big pharma. In case you haven’t noticed Altria is struggling to maintain market share in their space and MJ (with an aligning business model) will provide the diversification they need to renew growth. The same can be said for big pharma; those that are struggling in their space will branch out to CBD production-CBD oil if marketed aggressively can be a winner on par with Viagra. If I were Pfizer I would be targeting ICC out of Uruguay, they are a very low cost CBD oil producer with big ambitions. But hey, keep shorting, one day your going to wake up and you will see ACB (or one of the others) up $15/share based on an all cash offer.